|Bid||46.50 x 900|
|Ask||48.15 x 1200|
|Day's Range||47.29 - 50.60|
|52 Week Range||25.49 - 58.47|
|Beta (5Y Monthly)||1.46|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jul 29, 2021 - Aug 02, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||70.40|
The latest analyst coverage could presage a bad day for Apellis Pharmaceuticals, Inc. ( NASDAQ:APLS ), with the...
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Apellis' (APLS) earnings lag estimates in the first quarter of 2021. Main focus of the company is on its lead pipeline candidate, pegcetacoplan.